The Coronavirus Has One Strategy We Can’t Vaccinate Against

THE ATLANTIC - These intercellular messages, ferried about by molecules called interferons, serve as a warning signal to nearby cells—“‘You are about to be infected; it’s time for you to set up an antiviral state,’” says Juliet Morrison, an immunologist at UC Riverside . Recipient cells start battening down the hatches, switching on hundreds of...
By Katherine J. Wu | The Atlantic |
Drs Kaloshian and Borkovich in COVID-19 lab at MRB

In-house coronavirus testing draws attention of SoCal media

UC Riverside’s “homemade” COVID-19 testing lab has drawn widespread attention from Southern California media. The acknowledgment of the new lab’s success comes at a time when some universities across the nation have struggled to prevent campus outbreaks. The lab – created by UCR faculty – places the university in the elite company of universities including...
By Madeline Adamo | UCR News |

UC Riverside creates on-campus testing lab, tests students twice per week

KNBC-TV / TELEMUNDO -- KNBC speaks with members of the UCR campus community about the new COVID-19 testing lab on campus. Watch the video on KNBC-TV: Watch video in English Watch the video on Telemundo: Watch video in Spanish
By KNBC-TV / TELEMUNDO |

UC Riverside unveils on-campus coronavirus testing lab

FORBES - UC Riverside is doing its own testing for the novel coronavirus . The Inland Empire campus of about 25,000 students opened a COVID-19 testing laboratory in September and is processing 400 test samples per day, said Rodolfo Torres, vice chancellor for research and economic development. “We’ve been operating at full speed,” Torres said...
By David Downey | The Press-Enterprise |
COVID-19 coronavirus test lab on campus

Coronavirus lab and testing in place for fall quarter

As the fall quarter begins, UC Riverside has a new diagnostic lab operating on campus that will rapidly process samples from students and employees as part of an ongoing coronavirus testing program. The lab, located at the Multidisciplinary Research Building, or MRB, tested its first sample in August and opened in early September. The result...
By Imran Ghori | UCR News |
COVID-19 testing on the UCR campus

COVID-19 lab begins testing campus community

UC Riverside has begun testing students, staff, and faculty members for the coronavirus with the opening of a new diagnostic lab on campus this month. The lab, located at the Multidisciplinary Research Building, or MRB, began operations in early September. The facility allows the campus to conduct its own independent testing at a faster rate...
By Imran Ghori | Inside UCR |

Your Coronavirus Test Is Positive. Maybe It Shouldn’t Be.

THE NEW YORK TIMES - Some of the nation’s leading public health experts are raising a new concern in the endless debate over coronavirus testing in the United States: The standard tests are diagnosing huge numbers of people who may be carrying relatively insignificant amounts of the virus. Any test with a cycle threshold above...
By Apoorva Mandavilli | The New York Times |
Assistant Professor Rong Hai prepares equipment in the COVID-19 testing lab (UCR/Stan Lim)

Campus COVID-19 testing lab to open

UC Riverside is opening a diagnostic lab that will allow for expanded and rapid testing of students, staff, and faculty members for the coronavirus. The COVID-19 testing lab, located at the Multidisciplinary Research Building, or MRB, successfully tested its first sample on Aug. 12 and is expected to open in September. The lab will allow...
By Imran Ghori | Inside UCR |
Dr. Prue Talbot in a lab with students

Cell biologist to study coronavirus-related infection of respiratory cells

Prue Talbot, a professor of cell biology at UC Riverside, has received a seed grant to study the COVID-19-related infection of respiratory cells. She and her team will use the funds to test the hypothesis that electronic cigarettes and nicotine increase the ACE2 receptor on respiratory epithelium, providing more binding sites for the virus and...
By IQBAL PITTALWALA | Inside UCR |

Gilead poised to upend market with its first Covid-19 study data

BLOOMBERG - Gilead Sciences Inc. , whose Covid-19 treatment has whipsawed markets amid conflicting early reports about its efficacy, is set to report the first results from a company-sponsored study of the experimental drug. Data from the first 400 severely ill coronavirus patients being treated with Remdesivir in an open-label study are expected before the...
By Cristin Flanagan | Bloomberg |
Let us help you with your search